HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wellness Industry News: Homeopathic Conference, Neidig Leads USANA China, More

Executive Summary

CRN salutes former executive and influential nutritional ingredient researcher John Hathcock; AAHP tackles changing homeopathic industry regulation at first Summit; USANA appoints head of China business; supplements launch for brain health, hair growth and prenatal care.

You may also be interested in...



Hain Celestial Looking For Deals As Net Cash Jumps, Portfolio Slims

Hain Celestial looks for acquisitions while continuing to pare down its portfolio as its North America business sales grew 3% to $280.7m in its latest quarter.

OTC Homeopathic Market Could Shrink Under US FDA Risk-Based Oversight, Trade Groups Say

US FDA’s draft guidance for homeopathic products could result in consumer confusion, force sales of the products largely online and create a three-year backlog in review of products that have a safe track record, industry trade tells the agency. Agency plans to replace the existing compliance policy guide that largely delegated oversight to the Homeopathic Pharmacopeia of the US with risk-based enforcement by FDA.

People In Brief

CRN’s Hathcock retires; actress Vardalos takes on “Life…supplemented” role; pharma vet Freeman joins Health Enhancement Products; Boylan brings PR, advocacy experience to NACDS; Kalsec adds Barry as marketing, product management VP.

Topics

Related Companies

UsernamePublicRestriction

Register

RS148797

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel